These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8709863)
1. Relationship of HIV-1 envelope V2 and V3 sequences of the primary isolates to the viral phenotype. Yoshimura K; Matsushita S; Hayashi A; Takatsuki K Microbiol Immunol; 1996; 40(4):277-87. PubMed ID: 8709863 [TBL] [Abstract][Full Text] [Related]
2. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. De Wolf F; Hogervorst E; Goudsmit J; Fenyö EM; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala SD AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192 [TBL] [Abstract][Full Text] [Related]
3. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells. Todd BJ; Kedar P; Pope JH J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129 [TBL] [Abstract][Full Text] [Related]
4. Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1. Mammano F; Salvatori F; Ometto L; Panozzo M; Chieco-Bianchi L; De Rossi A J Virol; 1995 Jan; 69(1):82-92. PubMed ID: 7527089 [TBL] [Abstract][Full Text] [Related]
5. Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites. Cornelissen M; Hogervorst E; Zorgdrager F; Hartman S; Goudsmit J AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1169-75. PubMed ID: 8573372 [TBL] [Abstract][Full Text] [Related]
6. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. Cornelissen M; Mulder-Kampinga G; Veenstra J; Zorgdrager F; Kuiken C; Hartman S; Dekker J; van der Hoek L; Sol C; Coutinho R J Virol; 1995 Mar; 69(3):1810-8. PubMed ID: 7853521 [TBL] [Abstract][Full Text] [Related]
7. V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells. De Jong J; Simon F; Van der Groen G; Baan E; Saragosti S; Brun-Vézinet F; Goudsmit J AIDS Res Hum Retroviruses; 1996 Nov; 12(16):1503-7. PubMed ID: 8911575 [TBL] [Abstract][Full Text] [Related]
8. Genetically and epidemiologically related "non-syncytium-inducing" isolates of HIV-1 display heterogeneous growth patterns in macrophages. Aquino-De Jesus MJ; Anders C; Miller G; Sleasman JW; Goodenow MM; Andiman WA J Med Virol; 2000 Jun; 61(2):171-80. PubMed ID: 10797371 [TBL] [Abstract][Full Text] [Related]
9. Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children. Tuttle DL; Anders CB; Aquino-De Jesus MJ; Poole PP; Lamers SL; Briggs DR; Pomeroy SM; Alexander L; Peden KW; Andiman WA; Sleasman JW; Goodenow MM AIDS Res Hum Retroviruses; 2002 Mar; 18(5):353-62. PubMed ID: 11897037 [TBL] [Abstract][Full Text] [Related]
10. A group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressure. Shiino T; Kato K; Kodaka N; Miyakuni T; Takebe Y; Sato H J Virol; 2000 Feb; 74(3):1069-78. PubMed ID: 10627516 [TBL] [Abstract][Full Text] [Related]
11. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692 [TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. de Jong JJ; Goudsmit J; Keulen W; Klaver B; Krone W; Tersmette M; de Ronde A J Virol; 1992 Feb; 66(2):757-65. PubMed ID: 1731110 [TBL] [Abstract][Full Text] [Related]
13. In vivo sequence changes of HIV-1 envelope V2 and V3 loops. Shioda T; Oka S; Nagai Y Leukemia; 1997 Apr; 11 Suppl 3():131-3. PubMed ID: 9209320 [TBL] [Abstract][Full Text] [Related]
14. Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies. Hogervorst E; de Jong J; van Wijk A; Bakker M; Valk M; Nara P; Goudsmit J J Virol; 1995 Oct; 69(10):6342-51. PubMed ID: 7666535 [TBL] [Abstract][Full Text] [Related]
15. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. Abebe A; Demissie D; Goudsmit J; Brouwer M; Kuiken CL; Pollakis G; Schuitemaker H; Fontanet AL; Rinke de Wit TF AIDS; 1999 Jul; 13(11):1305-11. PubMed ID: 10449282 [TBL] [Abstract][Full Text] [Related]
16. Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1. McDonald RA; Chang G; Michael NL J Hum Virol; 2001; 4(4):179-87. PubMed ID: 11694845 [TBL] [Abstract][Full Text] [Related]
17. Blood monocytes infected in vivo by HIV-1 variants with a syncytium-inducing phenotype. Innocenti-Francillard P; Brengel K; Guillon C; Mallet F; Morand P; Gruters R; Seigneurin JM AIDS Res Hum Retroviruses; 1994 Jun; 10(6):683-90. PubMed ID: 8074932 [TBL] [Abstract][Full Text] [Related]
18. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204 [TBL] [Abstract][Full Text] [Related]
19. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. Kuiken CL; de Jong JJ; Baan E; Keulen W; Tersmette M; Goudsmit J J Virol; 1992 Jul; 66(7):4622-7. PubMed ID: 1602564 [TBL] [Abstract][Full Text] [Related]
20. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. Donaldson YK; Bell JE; Holmes EC; Hughes ES; Brown HK; Simmonds P J Virol; 1994 Sep; 68(9):5991-6005. PubMed ID: 7545945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]